FGEN logo

FibroGen, Inc. (FGEN)

Profile

Full Name

FibroGen, Inc.

Ticker

NASDAQ: FGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 14, 2014

Indexes

Not included

Website

https://www.fibrogen.com

Employees

225

Key Details

Price

$11.18(1.36%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$29.62M(-36.71% YoY)

Annual EPS

-$11.89(83.72% YoY)

PE Ratio

4.56

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.18
    FGEN price is $11.18

    30-Day Relative Volume

    1.16
    FGEN 30-day relative volume is 1.16

    Price Performance

    Price 1-Day Change

    +1.36%
    FGEN price is up +1.36% today

    Price YTD Change

    -15.62%
    FGEN price is down -15.62% since January 1st

    Price 1-Year Change

    +38.45%
    FGEN price is up +38.45% year-on-year

    Price 3-Year Change

    -97.23%
    FGEN price is down -97.23% over the past 3 years

    Price Range

    Price All-Time High

    $1713.75
    FGEN price is currently -99.35% below its historical high of $1713.75

    Price 3-Year Low

    $4.50
    FGEN price is currently +148.44% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $45.19M
    FGEN market cap is $45.19 million

    Market Cap 3-Year Change

    -97.02%
    FGEN market cap is down -97.02% over the past 3 years

    Market Cap All-Time High

    $5.66B
    FGEN market cap is currently -99.20% below its historical high of $5.66 billion

    Market Cap Sector Percentile

    32.3%
    FGEN market cap is higher than 32.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.27%
    FGEN shares outstanding is up +0.27% year-on-year

    Shares Outstanding 3-Year Change

    +7.54%
    FGEN shares outstanding is up +7.54% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.37
    FGEN beta is 1.37

    200-day SMA

    $9.41
    FGEN price is currently +18.86% above its 200-day simple moving average

    50-day SMA

    $11.42
    FGEN price is currently -2.12% below its 50-day simple moving average

    14-Day RSI

    49.23
    FGEN 14-day relative strength index is 49.23

    Volume

    1.16
    FGEN 30-day relative volume is 1.16

    ATR

    $0.46
    FGEN average true range is $0.46

    10-day Historical Volatility

    22.73%
    FGEN 10-day historical volatility is 22.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $29.62M
    FGEN annual revenue is $29.62 million

    Revenue Analysts Estimate

    $6.90M
    FGEN annual revenue is currently +329.29% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -36.71%
    FGEN annual revenue is down -36.71% year-on-year

    Revenue Sector Percentile

    56.8%
    FGEN annual revenue is higher than 56.8% of companies in Healthcare sector

    EPS

    EPS

    -$11.89
    FGEN annual earnings per share is -$11.89

    EPS Analysts Estimate

    -$4.17
    FGEN annual earnings per share is currently -185.12% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +83.72%
    FGEN annual earnings per share is up +83.72% year-on-year

    EPS Sector Percentile

    13.03%
    FGEN annual earnings per share is higher than 13.03% of companies in Healthcare sector

    Profit

    Gross Profit

    $14.06M
    FGEN annual gross profit is $14.06 million

    Gross Margin

    47.47%
    FGEN annual gross profit margin is 47.47%

    Operating Profit

    -$130.96M
    FGEN annual operating income is -$130.96 million

    Operating Margin

    -442.13%
    FGEN annual operating profit margin is -442.13%

    Net Income

    -$153.10M
    FGEN annual net profit is -$153.10 million

    Net Margin

    -160.63%
    FGEN annual net profit margin is -160.63%

    Expenses

    Total Expenses

    $160.58M
    FGEN annual total expenses is $160.58 million

    Operating Expenses

    $145.02M
    FGEN annual total operating expenses is $145.02 million

    Cost Of Goods Sold

    $15.56M
    FGEN annual cost of goods sold is $15.56 million

    Selling, General & Administrative Expenses

    $49.33M
    FGEN annual SG&A is $49.33 million

    Depreciation & Amortization

    $2.69M
    FGEN annual D&A is $2.69 million

    Interest Expense

    $8.25M
    FGEN annual interest expense is $8.25 million

    Income Tax

    -$269.00K
    FGEN annual income tax is -$269.00 thousand

    EBIT & EBITDA

    EBIT

    -$145.12M
    FGEN annual earnings before interest & taxes is -$145.12 million

    EBITDA

    -$142.43M
    FGEN annual EBITDA is -$142.43 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $214.53M
    FGEN annual total assets is $214.53 million

    Non Current Assets

    $18.02M
    FGEN annual long term assets is $18.02 million

    Current Assets

    $196.51M
    FGEN annual total current assets is $196.51 million

    Cash and Cash Equivalents

    $50.48M
    FGEN annual cash & cash equivalents is $50.48 million

    Accounts Receivable

    $481.00K
    FGEN annual accounts receivable is $481.00 thousand

    Inventory

    $3.15M
    FGEN annual inventory is $3.15 million

    Liabilities

    Total Liabilities

    $398.16M
    FGEN annual total liabilities is $398.16 million

    Long Term Liabilities

    $264.85M
    FGEN annual total long term liabilities is $264.85 million

    Current Liabilities

    $133.31M
    FGEN annual current liabilities is $133.31 million

    Accounts Payable

    $5.06M
    FGEN annual accounts payable is $5.06 million

    Debt

    Total Debt

    $90.21M
    FGEN annual total debt is $90.21 million

    Total Debt 1-Year Change

    -46.15%
    FGEN annual total debt is down -46.15% year-on-year

    Long Term Debt

    $73.09M
    FGEN annual long term debt is $73.09 million

    Short Term Debt

    $34.00K
    FGEN annual short term debt is $34.00 thousand

    Equity & Capital

    Shareholders Equity

    -$225.60M
    FGEN annual stockholders equity is -$225.60 million

    Book Value

    -$225.60M
    FGEN annual book value is -$225.60 million

    Retained Earnings

    -$1.89B
    FGEN annual retained earnings is -$1.89 billion

    Working Capital

    $63.20M
    FGEN annual working capital is $63.20 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$138.00M
    FGEN annual cash from operations is -$138.00 million

    Cash From Operations 1-Year Change

    +56.19%
    FGEN annual cash from operations is up +56.19% year-on-year

    Cash From Investing

    $125.99M
    FGEN annual cash from investing is $125.99 million

    Cash From Investing 1-Year Change

    -18%
    FGEN annual cash from investing is down -18% year-on-year

    Cash From Financing

    -$255.00K
    FGEN annual cash from financing is -$255.00 thousand

    Cash From Financing 1-Year Change

    -100.21%
    FGEN annual cash from financing is down -100.21% year-on-year

    CAPEX

    CAPEX

    $266.00K
    FGEN annual capital expenditures is $266.00 thousand

    CAPEX 1-Year Change

    -89.44%
    FGEN annual capital expenditures is down -89.44% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$138.26M
    FGEN annual free cash flow is -$138.26 million

    Free Cash Flow 1-Year Change

    +56.46%
    FGEN annual free cash flow is up +56.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    47.47%
    FGEN annual gross profit margin is 47.47%

    Operating Margin

    -442.13%
    FGEN annual operating profit margin is -442.13%

    Net Margin

    -160.63%
    FGEN annual net profit margin is -160.63%

    ROA & ROE

    ROA

    -47.99%
    FGEN annual return on assets is -47.99%

    ROE

    67.86%
    FGEN annual return on equity is 67.86%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    4.56
    FGEN price to earnings ratio is 4.56

    PE Ratio Sector Percentile

    4.93%
    FGEN price to earnings ratio is higher than 4.93% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    -0.20
    FGEN price to book ratio is -0.20

    PB Ratio Sector Percentile

    13.63%
    FGEN price to book ratio is higher than 13.63% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.84
    FGEN price to sales ratio is 0.84

    PS Ratio Sector Percentile

    20.1%
    FGEN price to sales ratio is higher than 20.1% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $114.95M
    FGEN enterprise value is $114.95 million

    Enterprise Value Sector Percentile

    47%
    FGEN enterprise value is higher than 47% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.93
    FGEN EV/EBITDA is -3.93

    EV/EBITDA Sector Percentile

    27.32%
    FGEN EV/EBITDA is higher than 27.32% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.47
    FGEN annual current ratio is 1.47

    Quick Ratio

    1.45
    FGEN annual quick ratio is 1.45

    Leverage

    Debt To Equity

    -0.32
    FGEN annual debt to equity ratio is -0.32

    Interest Coverage Ratio

    -17.60
    FGEN annual interest coverage ratio is -17.60

    Risk & Stability

    F-Score

    4
    FGEN piotroski f-score is 4

    Altman Z-Score

    -14.00
    FGEN altman z-score is -14.00

    Analyst ratings

    Recent major analysts updates

    Sep 24, 25 HC Wainwright & Co.
    Buy
    Aug 7, 25 HC Wainwright & Co.
    Buy
    May 13, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 HC Wainwright & Co.
    Buy
    Feb 20, 25 HC Wainwright & Co.
    Buy
    Aug 8, 23 B of A Securities
    Underperform
    Jun 27, 23 Raymond James
    Market Perform
    Jun 27, 23 Goldman Sachs
    Sell
    Jun 26, 23 William Blair
    Market Perform
    Jun 26, 23 Stifel
    Hold

    Institutional Ownership

    Screeners with FGEN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    Earnings today
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for FibroGen, Inc.?
    • Does FibroGen, Inc. pay dividends?
    • What sector is FibroGen, Inc. in?
    • What industry is FibroGen, Inc. in?
    • What country is FibroGen, Inc. based in?
    • When did FibroGen, Inc. go public?
    • Is FibroGen, Inc. in the S&P 500?
    • Is FibroGen, Inc. in the NASDAQ 100?
    • Is FibroGen, Inc. in the Dow Jones?
    • When was FibroGen, Inc.'s last earnings report?
    • When does FibroGen, Inc. report earnings?

    What is the ticker symbol for FibroGen, Inc.?

    The ticker symbol for FibroGen, Inc. is NASDAQ:FGEN

    Does FibroGen, Inc. pay dividends?

    No, FibroGen, Inc. does not pay dividends

    What sector is FibroGen, Inc. in?

    FibroGen, Inc. is in the Healthcare sector

    What industry is FibroGen, Inc. in?

    FibroGen, Inc. is in the Biotechnology industry

    What country is FibroGen, Inc. based in?

    FibroGen, Inc. is headquartered in United States

    When did FibroGen, Inc. go public?

    FibroGen, Inc.'s initial public offering (IPO) was on November 14, 2014

    Is FibroGen, Inc. in the S&P 500?

    No, FibroGen, Inc. is not included in the S&P 500 index

    Is FibroGen, Inc. in the NASDAQ 100?

    No, FibroGen, Inc. is not included in the NASDAQ 100 index

    Is FibroGen, Inc. in the Dow Jones?

    No, FibroGen, Inc. is not included in the Dow Jones index

    When was FibroGen, Inc.'s last earnings report?

    FibroGen, Inc.'s most recent earnings report was on August 11, 2025

    When does FibroGen, Inc. report earnings?

    The next expected earnings date for FibroGen, Inc. is November 10, 2025
    On this page